SEC Company Response from Histogen Inc. (CIK 0001383701) — Aug 3, 2022
Histogen Inc. (CIK 0001383701)
Date: Aug. 3, 2022 · CIK: 0001383701 · Accession: 0001193125-22-210675
AI Filing Summary & Sentiment
File numbers found in text: 333-266366
Letter
Re: Histogen Inc.
August 3, 2022
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549-4561
Attn: Dan Crawford
Registration Statement on Form S-3
File No. 333-266366
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Histogen Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement to 4:00 p.m., Eastern Standard Time, on Wednesday, August 3, 2022, or as soon thereafter as practicable.
Please contact Larry Nishnick of DLA Piper LLP (US) with any questions or comments at (858) 677-1414. Thank you for your assistance with this filing.
Very truly yours,
Histogen, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP August 3, 2022 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Dan Crawford Re: Histogen Inc. Registration Statement on Form S-3 File No. 333-266366 Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Histogen Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement to 4:00 p.m., Eastern Standard Time, on Wednesday, August 3, 2022, or as soon thereafter as practicable. Please contact Larry Nishnick of DLA Piper LLP (US) with any questions or comments at (858) 677-1414. Thank you for your assistance with this filing. Very truly yours, Histogen, Inc. By: /s/ Susan A. Knudson Name: Susan A. Knudson Title: Chief Financial Officer CC: Steven J. Mento, Ph.D., Histogen, Inc. Larry Nishnick, DLA Piper LLP (US)